Susten 200 mg (Progesterone)

Product Overview

Susten 200 mg (Progesterone) is a synthetic, bio‑identical progesterone preparation manufactured by Sun Pharmaceutical Industries Ltd. The medication is supplied in a strip containing ten soft gelatin capsules, each delivering a precise dose of 200 mg of progesterone. It is formulated for oral administration and is indicated primarily for the management of female infertility and as an adjunct in hormone replacement therapy for conditions associated with luteal phase deficiency or estrogen deficiency in post‑menopausal women.

What is Susten 200 mg (Progesterone)

Progesterone is a steroid hormone synthesized in the ovary, placenta, and adrenal cortex. It plays a central role in preparing the endometrium for implantation, maintaining early pregnancy, and regulating the menstrual cycle. The molecule binds to intracellular progesterone receptors, influencing gene transcription pathways that control cellular proliferation, angiogenesis, and immune modulation. Susten provides a pharmacologic dose that replicates the natural hormone’s actions, thereby supporting physiological processes that may be compromised in certain clinical states.

Uses and Benefits

The therapeutic uses of Susten 200 mg encompass a broad spectrum of gynecologic and reproductive indications:

• Maintenance of the luteal phase in assisted reproductive technology cycles, improving implantation rates.
• Support of early pregnancy in women with a history of recurrent miscarriage or progesterone deficiency.
• Adjunctive component of combined estrogen‑progestin regimens for hormone replacement therapy, reducing the risk of endometrial hyperplasia.
• Treatment of anovulatory cycles and irregular uterine bleeding linked to insufficient endogenous progesterone.
• Management of certain cases of endometriosis when progesterone therapy is part of a symptom‑control strategy.

Benefits are derived from the drug’s molecular identity with endogenous progesterone, which confers a high affinity for progesterone receptors and a predictable pharmacokinetic profile. This results in a low incidence of receptor‑specific adverse effects compared with synthetic progestins that possess altered steroid structures.

How It Works

Following oral ingestion, Susten capsules release progesterone gradually, achieving peak serum concentrations within 6 to 8 hours. The drug’s half‑life of approximately 10–12 hours supports once‑daily dosing, typically taken at bedtime to align with the natural nocturnal rise in progesterone. Once absorbed, progesterone diffuses into target cells and binds to cytosolic progesterone receptors, forming a hormone‑receptor complex that translocates to the nucleus. There, the complex modulates transcription of genes involved in endometrial secretory transformation, vascular permeability, and immunomodulation.

The resulting endometrial changes create a receptive environment for embryo implantation and help sustain pregnancy. Additionally, progesterone exerts systemic calming effects on the hypothalamic‑pituitary‑gonadal axis, which can mitigate hyperandrogenic symptoms and stabilize menstrual patterns.

Dosage Guidelines

Dosage must be individualized by a qualified clinician based on the patient’s diagnostic work‑up, response to therapy, and concomitant medications. The most common regimen is one 200 mg soft gelatin capsule taken orally at nightly intervals. In certain hormone replacement protocols, a cyclic schedule (e.g., 10–14 days per month) may be employed, while continuous dosing is reserved for specific clinical scenarios.

For patients undergoing in‑vitro fertilization, some protocols recommend a loading phase of two capsules daily for the first three days followed by a maintenance dose of one capsule nightly. Adjustments are guided by serum progesterone measurements and ultrasound findings, and any dose modification should be performed under medical supervision.

Special populations, such as elderly women or those with hepatic impairment, may require dose reduction and closer monitoring due to altered drug clearance.

Side Effects

Adverse reactions to Susten are generally mild and transient, but patients should be aware of possible outcomes:

• Gastrointestinal discomfort, including bloating, nausea, or mild abdominal cramping.
• Central nervous system effects such as dizziness, headache, or somnolence.
• Breast tenderness or enlargement.
• Changes in libido or mood.
• Rare occurrences of thromboembolic events, especially in patients with pre‑existing risk factors.

Most side effects resolve without intervention; however, persistent or severe symptoms warrant immediate medical evaluation. Patients are advised to report any unexpected bleeding, visual disturbances, or signs of allergic reaction.

Warnings and Precautions

Prior to initiating therapy, clinicians should perform a comprehensive assessment of the following:

• Personal or family history of thromboembolic disease, cardiovascular disorders, or stroke.
• Active or chronic liver disease, as hepatic metabolism may be compromised.
• Pregnancy status, unless Susten is specifically prescribed for pregnancy maintenance.
• Breastfeeding, where limited data exist regarding infant exposure.
• Concomitant use of enzyme‑inducing agents (e.g., rifampin, carbamazepine) that may reduce serum progesterone levels.

Patients should be instructed to avoid driving or operating heavy machinery if they experience marked drowsiness or dizziness. Regular follow‑up visits are recommended to monitor therapeutic response and to reassess the need for continued treatment.

For comprehensive prescribing information, healthcare professionals may consult the product’s official label, the U.S. Food and Drug Administration, or the National Center for Biotechnology Information.

Frequently Asked Questions

1. What is the recommended storage condition for Susten 200 mg?
Store the capsules at room temperature, away from moisture and direct sunlight. Keep the strip sealed until ready for use.

2. Can Susten be taken with other medications?
Susten may interact with drugs that affect cytochrome P450 enzymes. Concomitant use with certain anticonvulsants, corticosteroids, or herbal supplements should be reviewed by a physician.

3. How long does it take to see a therapeutic effect?
Improvement in menstrual regularity or support for assisted reproduction is typically observed after several cycles, often within 4–6 weeks of consistent dosing.

4. Is Susten safe for women with a history of breast cancer?
The safety of Susten in breast cancer survivors has not been fully established. Women with a history of hormone‑sensitive breast cancer should discuss potential risks with their oncologist.

5. Where can I purchase Susten 200 mg?
Susten is dispensed by prescription from licensed pharmacies and may be available through authorized online pharmacy platforms that comply with local regulatory standards.

Related Products

• Famotidine 20mg (Generic)
• Omesec 20 mg (Omeprazole)
• Pantocid DSR (Pantoprazole/Domperidone)
• Famotidine 40mg (Generic)
• Famocid 20mg (Famotidine)
• Famocid 40mg (Famotidine)
• Famocid (Famotidine)
• Supatret 0.04% Gel (Tretinoin)
• Supatret 0.1% Gel (Tretinoin)
• Supatret C Gel (Clindamycin/Tretinoin)
• Supatret Gel (Tretinoin)
• Acitretin 25mg (Generic)